Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 31, 2005
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the year and fourth quarter ended December 31, 2005.
-
Oct 17, 2005
BEACH trial evaluated the benefits of carotid artery stenting (CAS) in conjunction with embolic protection for the treatment of carotid artery disease.
-
Oct 14, 2005
Boston Scientific Corporation (NYSE: BSX) today announced financial results for its third quarter ended September 30, 2005. Read the highlights.
-
Oct 10, 2005
(October 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company
-
Oct 3, 2005
New facility includes research and development labs, the Cardiovascular Technology and Product Development organization and other supporting functions.
-
Sep 19, 2005
New complex will serve as the new headquarters for the Company.
-
Aug 2, 2005
The twins took part in a groundbreaking study investigating the effectiveness of bilateral implants as a treatment for deafness in young children.
-
Jul 28, 2005
Award recognizes Company's successful efforts to increase efficiencies in the global supply chain.
-
Jul 19, 2005
"We are pleased with the second quarter results, which featured double digit growth on a global basis," said Jim Tobin, President and CEO.
-
Jul 11, 2005
Precision system is an implantable neurostimulator that masks pain signals.
-
Jul 8, 2005
Innovation represents the latest in treating brain aneurysm
-
Jul 7, 2005
A live webcast and replay of the Tuesday, July 19 session will be available. Learn how to tune in.
-
Jul 1, 2005
Johnson & Johnson's devices found to have infringed two Company patents
-
Jun 27, 2005
(June 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling worldwide all Hemashield® VANTAGE™ Vascular Grafts, which are used in peripheral...
-
Jun 24, 2005
(June 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement agreement with the U.S. Department of Justice regarding the Department's...
-
Jun 21, 2005
(June 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a jury in a patent infringement case in U.S. District Court in Delaware brought by Johnson & Johnson (NYSE: JNJ)...
-
Jun 20, 2005
OLYMPIA registry plans to enroll more than 30,000 patients at more than 600 centers around the world.
-
Jun 14, 2005
Company completes final phase; Rubicon now a wholly-owned subsidiary.
-
Jun 9, 2005
A live webcast and replay of the Wednesday, June 15 session will be available. Learn how to tune in.
-
Jun 9, 2005
Dutch court rules that a subsidiary of Johnson & Johnson infringed a Boston Scientific balloon catheter patent.
-
Jun 1, 2005
Quinn will be responsible for Company-wide human resources efforts, supporting all businesses, regions and functions.
-
May 25, 2005
The Company announced the estimates at a meeting of financial analysts held in conjunction with the Paris Course on Revascularization (EuroPCR).
-
May 25, 2005
TAXUS V trial is studying the most challenging lesions and highest-risk patients ever studied in a randomized, controlled clinical trial in the United States.
-
May 25, 2005
Thirty-day safety data reported from global ATLAS clinical trial.
-
May 25, 2005
Clinical findings announced at the annual Paris Course on Revascularization.